Viking Therapeutics, Inc. (VKTX) Total liabilities 2016–2025
Viking Therapeutics, Inc. (VKTX) total liabilities at each fiscal year-end, per SEC filings.
$76.7MFY2025 · since FY2016: $6.5M → $76.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $76.7M | +173.4% |
| FY2024 | $28.0M | +39.7% |
| FY2023 | $20.1M | -13.5% |
| FY2022 | $23.2M | +164.4% |
| FY2021 | $8.8M | -27.8% |
| FY2020 | $12.2M | +70.4% |
| FY2019 | $7.1M | +56.4% |
| FY2018 | $4.6M | -47.3% |
| FY2017 | $8.7M | +33.3% |
| FY2016 | $6.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice